MARKET

AVAI

AVAI

AVAI BIO
OTCMQB
0.169
-0.016
-8.86%
Closed 14:18 07/24 EDT
OPEN
0.185
PREV CLOSE
0.185
HIGH
0.187
LOW
0.169
VOLUME
87.00K
TURNOVER
15.43K
52 WEEK HIGH
0.800
52 WEEK LOW
0.110
MARKET CAP
25.95M
P/E (TTM)
-22.7838
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AVAI last week (0720-0724)?
Weekly Report · 4h ago
Stocks in play: Avai Bio Inc
Barchart · 5d ago
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
PR Newswire · 6d ago
Avai Bio, Austrianova reach deal with partner to supply insulin-producing cells for Insulinova diabetes therapy
PUBT · 6d ago
AVAÍ BIO AND AUSTRIANOVA REACH AGREEMENT FOR INSULIN-PRODUCING CELLS WITH INTERNATIONALLY ACCLAIMED PARTNER TO ADVANCE DIABETES THERAPY
Reuters · 6d ago
Weekly Report: what happened at AVAI last week (0713-0717)?
Weekly Report · 07/20 09:16
Avai Bio FY26 net loss widens 53% to USD 1.75 million
PUBT · 07/14 19:20
Weekly Report: what happened at AVAI last week (0706-0710)?
Weekly Report · 07/13 09:16
More
About AVAI
Avai Bio, Inc., formerly Avant Technologies, Inc., is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements developing cell-based therapies. The Company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an a-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments. It has secured Joint Venture and Licensing Agreements to develop both cell lines. Its diabetes program is focused on developing an insulin-producing cell line, then encapsulating those cells inside using SGAustria's Cell-in-a-Box technology to create a bio-artificial pancreas for type 1 and insulin-dependent type 2 diabetes. The Company is partnering with biotech firms, universities, scientists, and clinicians to uncover solutions for diverse healthcare challenges.

Webull offers Avai Bio Inc stock information, including OTCMQB: AVAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVAI stock methods without spending real money on the virtual paper trading platform.